NIDA Invisible Fit Sunscreen

Manufacturer
Proso Corp | Kolmar Korea Co., Ltd
Effective date
2026-01-08
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:33:42

Label at a glance#

ProductNIDA Invisible Fit Sunscreen
Active ingredientHOMOSALATE, OCTISALATE, OCTOCRYLENE
Label structure8 sections

Label contents#

Full prescribing information#

DOSAGE & ADMINISTRATION SECTION

Directions

Apply liberally 15 minutes before sun exposure

Sun protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: • Limit time in the sun, especially from 10a.m.– 2p.m. • Wear long-sleeved shirts, pants, hats, and sunglasses

Children under 6 months of age: Ask a doctor

Reapply at least every 2 hours

Use a water resistant sunscreen if swimming or sweating

WARNINGS SECTION

Warnings For external use only.

Do not use on damaged or broken skin.

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash occurs.

Keep out of reach of children. If swallowed get medical help or contact a Poison Control Center right away.

INDICATIONS & USAGE SECTION

Uses

Helps prevent sunburn

If used as directed with other sun protection measures (see Directions) decreases the risk of skin cancer and early skin aging caused by the sun

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed get medical help or contact a Poison Control Center right away.

OTC - PURPOSE SECTION

Purpose Sunscreen

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients

Homosalate [13.5%]

Octocrylene [9.0%]

Octisalate [4.5%]

Avobenzone [2.7%]

INACTIVE INGREDIENT SECTION

Inactive Ingredients

Water, Homosalate, Octocrylene, Butyloctyl Salicylate, Ethylhexyl Salicylate, Dipropylene Glycol, Butyl Methoxydibenzoylmethane, Panthenol, Diethylhexyl 2,6-Naphthalate, C20-22 Alkyl Phosphate, C20-22 Alcohols, 1,2-Hexanediol, Silica, Caprylyl Methicone, Pentylene Glycol, Cetyl Alcohol, Methyl Methacrylate Crosspolymer, Glyceryl Stearate, Tromethamine, Polyacrylate Crosspolymer-6, Ammonium Acryloyldimethyltaurate/Vp Copolymer, Fragrance, Ethylhexylglycerin, VP/Eicosene Copolymer, Tocopherol

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NIDA Invisible Fit SunscreenNIDA Invisible Fit Sunscreen

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
77dc03a4-fbfc-e6a3-fe95-285bbae40d75Product name220250814

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
87335-001-01NIDA Invisible Fit Sunscreen1 in 1 CARTONCREAM11
87335-001-01NIDA Invisible Fit Sunscreen50 g in 1 TUBECREAM501

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 27 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87335-00187335-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 25 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NIDA Invisible Fit SunscreenSUNSCREENProso Corp47ed3b62-45ef-b67a-e063-6294a90a317b2026-01-08WarningsExact identifier
ndc (package): 87335-001-01
ndc (product): 87335-001
ndc11 (package): 87335000101
spl id: 47ed3b62-45f0-b67a-e063-6294a90a317b
spl set id: 47ed3b62-45ef-b67a-e063-6294a90a317b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.